Thursday 25 Apr, 2024 05:59 AM
Site map | Locate Us | Login
   Axis Bank records turnaround PAT of Rs 7,130 cr in Q4    HUL Q4 PAT slides 6% YoY to Rs 2,406 cr; declares dividend of Rs 24/ share    RBI restricts Kotak Mahindra Bank's digital onboarding and credit card issuance    LTIMindtree Q4 PAT drops 6% QoQ to Rs 1,100 cr    Equitas SFB records 9% YoY growth in Q4 PAT; GNPA rise by Rs 97.32 crore    DCB Bank spurts after Q4 PAT climbs 10% YoY to Rs 156 cr    RVNL jumps after JV bags order from Southern Railway    Nippon Life AMC hits record high as Q4 PAT soars 73% YoY    Chennai Petro hits life high as Q4 PAT climbs 70% QoQ; declares dividend of Rs 55/sh    Vodafone Idea Ltd leads losers in 'A' group    Atal Realtech Ltd leads losers in 'B' group    Volumes soar at Chambal Fertilisers & Chemicals Ltd counter    IIFL Finance commences special audit directs by RBI    Information Technology shares fall    Telecom shares fall 
Saravan Stocks
       
Company Background
Dr Reddys Laboratories Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value(R) NSE Symbol Div & Yield % Market Cap (Rs.Cr) P/E(TTM) EPS(TTM) Face Value(R)
500124 INE089A01023 1361.8538112 DRREDDY 0.67 99325.26 24.96 238.56 5
Incorporation Year 1984  
Registered Office 8-2-337 Road No 3,Banjara Hills,
Hyderabad,
Telangana-500034
Telephone 91-40-49002900  
Fax 91-40-49002999  
Chairman K Satish Reddy  
Managing Director G V Prasad  
Company Secretary K Randhir Singh  
Auditor S R Batliboi & Associates LLP  
Face Value 5  
Market Lot 1  
Listing BSE,MSEI ,New York,NSE  
Registrar Big Share Services Pvt Ltd
3rd Flr 306 Rightwin,Amrutha Ville,Somajiguda,Hyderabad-500082
 
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 32117971
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd